Tirzepatide, a once-weekly GIP/GLP-1 receptor agonist, is a medicine used for weight reduction in adults with obesity. A new analysis of the SURMOUNT clinical trials reveals that the medicine, ...
Some peptides help promote weight loss by helping to regulate blood sugar levels, metabolism, and appetite. These medications may cause side effects and people must have a prescription to take them.
1monon MSN
Muscle loss vs fat loss: Why dropping weight too fast destroys your long-term metabolic rate
Dr. Amrita Ghosh explains the difference between muscle loss and fat loss. And if you drop weight too fast, it can destroy ...
In the context of the global obesity epidemic, the FDA approved several glucagon-like peptide-1 (GLP-1) receptor agonists (GPL-1RAs), such as liraglutide (Saxenda) and semaglutide (Ozempic, Wegovy) as ...
Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...
A new once-a-month injection helped people with obesity shed up to 16% of their body weight, offering fresh hope for effective, long-acting treatments. Can this breakthrough change the landscape for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results